首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Ecancermedicalscience

缩写:

ISSN:1754-6605

e-ISSN:1754-6605

IF/分区:1.5/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引2155条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Soumitra Shankar Datta,Soumita Ghose,Manisha Ghosh et al. Soumitra Shankar Datta et al.
Background: Much of the global cancer burden is in low- and middle-income countries (LMICs). Along with the high incidence of cancer, most LMICs have unevenly distributed health care resources. This study is a qualitative...
Gabriella Pravettoni,Marianna Masiero,Christine Mugo-Sitati et al. Gabriella Pravettoni et al.
Cancer prevention and control services worldwide must actively rebuild and contribute to improved health systems resilience alongside and beyond the COVID-19 (SARS-CoV-2 coronavirus disease) pandemic, especially in low- and middle-income co...
Ian F Tannock Ian F Tannock
Gordon McVie campaigned throughout his career for merging scientific and clinical expertise and for investigating the underlying pharmacokinetics and pharmacodynamics in clinical trials. This need remains highly relevant today when most can...
Soo-Peng Teoh,Yee-Yin Hoo,Raul Murillo et al. Soo-Peng Teoh et al.
Background: Many countries appear to be ill-prepared in their emergency responses towards the Corona Virus Disease 2019 (COVID-19) pandemic, particularly in managing chronic diseases such as cancer. We aimed to gain insig...
Isabel Saffie Vega,Jorge Sapunar Zenteno,Felipe Buscaglia Fernandez et al. Isabel Saffie Vega et al.
The human epidermal growth factor receptor 2 (ERBB2, HER2 or HER2/neu) is a transmembrane tyrosine kinase receptor that is overexpressed in approximately 20% of breast cancers. The use of the anti-HER2 monoclonal antibodies Pertuzumab and T...
Yan Fei Gu,Frank P Lin,Richard J Epstein Yan Fei Gu
Population aging is causing a demographic redistribution with implications for the future of healthcare. How will this affect oncology? First, there will be an overall rise in cancer affecting older adults, even though age-specific cancer i...
Martin Angel,Martin Zarba,Juan Pablo Sade Martin Angel
Poly (ADP-ribose) polymerase (PARP) inhibitors (iPARPs) have shown efficacy in homologous recombination (HR) deficiency patients with advanced castration resistant prostate cancer and have shown a radiosensitizing effect in preclinical and ...
Paromita Roya,Lateef Zameer,Debdeep Dey et al. Paromita Roya et al.
Purpose: Tumour budding (TB) is an important adverse prognostic factor in colon cancer, which can also guide adjuvant treatment in stage II colorectal carcinoma. The International Tumor Budding Consensus Conference (ITBCC...
Christian Colonio,Luciana Lecman,Joseph A Pinto et al. Christian Colonio et al.
Background: There is a large gap in the data on cancer outcomes in Latin America, making it difficult to establish adequate cancer control policies in the region. The aim of our study was to describe the survival, life ex...
Bivas Biswas,Gautam Biswas,Sandip Ganguly et al. Bivas Biswas et al.
Purpose: Malignant melanoma (MM) is rare in India. Indian data on demography and treatment outcome on advanced MM is very limited in the literature. Mater...